Common Contracts
4 similar Securities Purchase Agreement contracts by Amyris, Inc., EF Hutton Acquisition Corp I, Rock Creek Pharmaceuticals, Inc., Tellurian Inc. /De/
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 11th, 2023 • EF Hutton Acquisition Corp I • Motor vehicles & passenger car bodies • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 6, 2023, is by and among EF Hutton Acquisition Corporation I, a Delaware corporation with offices located at 24 Shipyard Drive, Suite 102, Hingham, MA 02043 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 28th, 2020 • Tellurian Inc. /De/ • Crude petroleum & natural gas • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 28, 2020, is by and among Tellurian Inc., a Delaware corporation with offices located at 1201 Louisiana Street, Suite 3100, Houston, Texas 77002 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 7th, 2018 • Amyris, Inc. • Industrial organic chemicals • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 6, 2018, is by and among Amyris, Inc., a Delaware corporation with offices located at 5885 Hollis Street, Suite 100, Emeryville, CA 94608 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 15th, 2015 • Rock Creek Pharmaceuticals, Inc. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 14, 2015, is by and among Rock Creek Pharmaceuticals, Inc., a Delaware corporation with offices located at 2040 Whitfield Ave., Ste. 300, Sarasota Florida 34240 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
